FMR LLC grew its stake in shares of Orthopediatrics Corp (NASDAQ:KIDS) by 8.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 414,600 shares of the company’s stock after acquiring an additional 33,000 shares during the period. FMR LLC owned about 3.24% of Orthopediatrics worth $14,462,000 at the end of the most recent reporting period.
Several other hedge funds also recently bought and sold shares of the company. RTW Investments LP purchased a new stake in shares of Orthopediatrics in the 4th quarter valued at approximately $7,848,000. Prospect Capital Advisors LLC purchased a new stake in shares of Orthopediatrics in the 4th quarter valued at approximately $7,136,000. Metropolitan Life Insurance Co. NY purchased a new stake in shares of Orthopediatrics in the 4th quarter valued at approximately $93,000. MetLife Investment Advisors LLC purchased a new stake in shares of Orthopediatrics in the 4th quarter valued at approximately $128,000. Finally, Bank of America Corp DE lifted its position in shares of Orthopediatrics by 1,421.8% in the 4th quarter. Bank of America Corp DE now owns 34,894 shares of the company’s stock valued at $1,218,000 after acquiring an additional 32,601 shares in the last quarter. Institutional investors own 45.14% of the company’s stock.
Several research analysts have weighed in on the stock. Zacks Investment Research upgraded shares of Orthopediatrics from a “hold” rating to a “buy” rating and set a $46.00 price objective on the stock in a research note on Saturday, March 16th. BidaskClub upgraded shares of Orthopediatrics from a “buy” rating to a “strong-buy” rating in a research note on Friday, March 1st. BTIG Research upped their price objective on shares of Orthopediatrics to $44.00 and gave the company a “buy” rating in a research note on Friday, March 8th. Finally, JMP Securities assumed coverage on shares of Orthopediatrics in a research note on Wednesday, February 20th. They issued an “outperform” rating and a $44.00 price objective on the stock. One analyst has rated the stock with a hold rating and six have given a buy rating to the stock. Orthopediatrics currently has an average rating of “Buy” and an average target price of $41.00.
Orthopediatrics (NASDAQ:KIDS) last announced its quarterly earnings results on Wednesday, March 6th. The company reported ($0.19) EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of ($0.19). Orthopediatrics had a negative net margin of 20.89% and a negative return on equity of 22.99%. The company had revenue of $14.60 million for the quarter, compared to analyst estimates of $14.50 million. During the same quarter in the prior year, the business posted ($1.41) EPS. Orthopediatrics’s quarterly revenue was up 24.8% on a year-over-year basis. Equities analysts anticipate that Orthopediatrics Corp will post -0.41 EPS for the current fiscal year.
COPYRIGHT VIOLATION WARNING: “Fmr LLC Has $14.46 Million Stake in Orthopediatrics Corp (NASDAQ:KIDS)” was originally reported by Baseball Daily News and is the sole property of of Baseball Daily News. If you are accessing this story on another domain, it was illegally stolen and reposted in violation of United States and international trademark and copyright legislation. The original version of this story can be accessed at https://www.baseballdailydigest.com/news/2019/04/15/fmr-llc-acquires-33000-shares-of-orthopediatrics-corp-kids.html.
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company's products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail products, PediLoc tibia products, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, RESPONSE Spine systems, Bandloc, and Pediguard.
Featured Article: What is a trade deficit?
Receive News & Ratings for Orthopediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthopediatrics and related companies with MarketBeat.com's FREE daily email newsletter.